Mild Cognitive Impairment Clinical Trial
— TRAIN4BRAINOfficial title:
Effects of Different Resistance Training Volumes on Cognitive Function, Oxidative Stress, Immunological Response, Lipid Profile, Glycemic Status, Liver Function, Muscle Function, Hemodynamic Response, and Physical Performance in Individuals With Mild Cognitive Impairment
This research project aims to analyze the effects of different resistance training volumes on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment. First the investigators will analyze the effects of a single resistance training session (acute effects) with one and three sets on hemodynamic and physical performance in individuals with mild cognitive impairment. After, the investigators will analyze the effects of an 8-week resistance training program with one or three sets on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment. The investigators hypothesize that a single resistance training session of one or three sets will increase the acute hemodynamic and physical performance stress in individuals with mild cognitive impairment, although with a higher magnitude in the session with three sets. Furthermore, we hypothesize that eight weeks of resistance training with one or three sets will induce similar improvements in cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment.
Status | Recruiting |
Enrollment | 80 |
Est. completion date | April 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years and older |
Eligibility | Inclusion criteria: - Clinical diagnosis of mild cognitive impairment - SPPB score = 3 points - Willingness to participate in the interventions and collaborate with the research team - Must be able to provide informed consent (oral or written) Exclusion criteria: - Severe dementia - Severe comorbidity that negatively influences participation in the intervention - Color blindness - Fractures in the last three months |
Country | Name | City | State |
---|---|---|---|
Portugal | University of Beira Interior | Covilhã |
Lead Sponsor | Collaborator |
---|---|
University of Beira Interior | Research Center in Sports Sciences, Health Sciences and Human Development (CIDESD) |
Portugal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Systolic blood pressure (SBP) | In the cross-over study (acute effects), the SBP will be assessed through a blood pressure device. | Change from baseline to 0 minutes and 72 hours after the sessions | |
Primary | Handgrip strength (HGS) | In the cross-over study (acute effects), the HGS will be assessed through an analogic dynamometer. | Change from baseline to 0 minutes and 72 hours after the sessions | |
Primary | Dementia Rating Scale-2 (DRS-2) | In the eight-week study, the DRS-2 questionnaire will be applied to analyze the overall level of cognitive function through five subscales: attention, initiation/perseveration, construction, conceptualization, and memory. | Change from baseline to week 8 | |
Primary | Brain-Derived Neurotrophic Factor (BDNF) | In the eight-week study, the BDNF protein levels will be analyzed through specific blood testing kits. | Change from baseline to week 8 | |
Primary | Short Physical Performance Battery (SPPB) | In the eight-week study, the SPPB will determine the overall level of functional performance through three tests: balance (feet side by side, semi tandem, tandem), 4-meter walking, and 5-repetition sit-to-stand. | Change from baseline until week 8 | |
Secondary | Diastolic blood pressure (DBP) | In the cross-over study (acute effects), the DBP will be assessed through a blood pressure device. | Change from baseline to 0 minutes and 72 hours after the sessions | |
Secondary | Heart rate (HR) | In the cross-over study (acute effects), the HR will be assessed through a blood pressure device. | Change from baseline to 0 minutes and 72 hours after the sessions | |
Secondary | Tympanic temperature (TT) | In the cross-over study (acute effects), the TT will be assessed through a tympanic thermometer. | Change from baseline to 0 minutes and 72 hours after the sessions | |
Secondary | Five-repetition sit-to-stand (5STS) | In the cross-over study (acute effects), the 5STS time will be recorded through a chronometer. | Change from baseline to 0 minutes and 72 hours after the sessions | |
Secondary | 1-kg Medicine Ball Throw (MBT) | In the cross-over study (acute effects), the MBT distance will be recorded with a tape measure. | Change from baseline to 0 minutes and 72 hours after the sessions | |
Secondary | Inflammatory markers | In the eight-week study, inflammatory markers (IL-6, TNF-a, and IL-10) will be analyzed through specific blood testing kits. | Change from baseline to week 8 | |
Secondary | Oxidative stress | In the eight-week study, oxidative stress markers (carbonylated proteins) will be analyzed through specific blood testing kits. | Change from baseline to week 8 | |
Secondary | Lipid Profile | In the eight-week study, the lipid profile (LDL, HDL, total cholesterol, triglycerides) will be analyzed through specific blood testing kits. | Change from baseline to week 8 | |
Secondary | HbA1c | In the eight-week study, the HbA1c will be analyzed through specific blood testing kits. | Change from baseline to week 8 | |
Secondary | Muscle Damage | In the eight-week study, the muscle damage (creatine kinase, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase) will be analyzed through specific blood testing kits. | Change from baseline to week 8 | |
Secondary | One-repetition maximum (1RM) | In the eight-week study, a progressive loading test until reaching the 1RM will be applied in the horizontal leg press and seated chest press machines. | Change from baseline to week 8 | |
Secondary | Load-velocity profiles | In the eight-week study, the load-velocity profiles will be analyzed using the velocity values (recorded with a linear velocity transducer) associated with the absolute loads used during the progressive loading tests in the horizontal leg press and seated chest press machines. | Change from baseline to week 8 | |
Secondary | Ten-meters walking | In the eight-week study, the 10-meter walking time will be measured through a chronometer. | Change from baseline to week 8 | |
Secondary | 1-kg Medicine Ball Throw (MBT) | In the eight-week study, the MBT distance will be recorded with a tape measure. | Change from baseline to week 8 | |
Secondary | Handgrip strength (HGS) | In the eight-week study, the HGS will be assessed through an analogic dynamometer. | Change from baseline to week 8 | |
Secondary | 6-Minute Walk Test (6MWT) | In the eight-week study, the 6MWT distance will be assessed by multiplying the number of total laps by the lap distance (e.g., 10 laps x 10 meters). | Change from baseline to week 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |